These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9864084)

  • 21. Recovery from new-onset diabetes in a schizophrenic man after withdrawal of olanzapine.
    Melkersson K; Hulting AL
    Psychosomatics; 2002; 43(1):67-70. PubMed ID: 11927762
    [No Abstract]   [Full Text] [Related]  

  • 22. Healthy outcome under olanzapine treatment in a pregnant woman.
    Kirchheiner J; Berghöfer A; Bolk-Weischedel D
    Pharmacopsychiatry; 2000 Mar; 33(2):78-80. PubMed ID: 10761825
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aggression, agitation, and mania with olanzapine.
    John V; Rapp M; Pies R
    Can J Psychiatry; 1998 Dec; 43(10):1054. PubMed ID: 9868577
    [No Abstract]   [Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome during olanzapine and levomepromazine treatment.
    Järventausta K; Leinonen E
    Acta Psychiatr Scand; 2000 Sep; 102(3):231-3. PubMed ID: 11008860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Case report of withdrawal syndrome after olanzapine discontinuation.
    Nayudu SK; Scheftner WA
    J Clin Psychopharmacol; 2000 Aug; 20(4):489-90. PubMed ID: 10917413
    [No Abstract]   [Full Text] [Related]  

  • 26. Olanzapine induced "typical" neuroleptic malignant syndrome.
    Goveas JS; Hermida A
    J Clin Psychopharmacol; 2003 Feb; 23(1):101-2. PubMed ID: 12544383
    [No Abstract]   [Full Text] [Related]  

  • 27. [Life threatening neuroleptic malignant syndrome due to olanzapine].
    Kopf A; Köster J; Schulz A; Krömker H; Becker T
    Psychiatr Prax; 2003 Jul; 30(5):279-82. PubMed ID: 12872187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Neuroleptic malignant syndrome and atypical antipsychotics].
    Canora Lebrato J; Bermúdez García JM; Alvarez García ML; Rico Irles J
    Med Clin (Barc); 2000 Sep; 115(7):279. PubMed ID: 11013157
    [No Abstract]   [Full Text] [Related]  

  • 29. Olanzapine induced neuroleptic malignant syndrome--a case review.
    Kogoj A; Velikonja I
    Hum Psychopharmacol; 2003 Jun; 18(4):301-9. PubMed ID: 12766935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome associated with olanzapine.
    Filice GA; McDougall BC; Ercan-Fang N; Billington CJ
    Ann Pharmacother; 1998 Nov; 32(11):1158-9. PubMed ID: 9825080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
    Malyuk R; Gibson B; Procyshyn RM; Kang N
    Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dystonia associated with olanzapine therapy.
    Gunal DI; Onultan O; Afsar N; Aktan S
    Neurol Sci; 2001 Aug; 22(4):331-2. PubMed ID: 11808858
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of preexisting diabetes with olanzapine.
    Littrell KH; Petty RG; Peabody CD; Hilligoss NM; Johnson CG
    J Clin Psychiatry; 2001 Sep; 62(9):733-4. PubMed ID: 11681771
    [No Abstract]   [Full Text] [Related]  

  • 34. Olanzapine-induced ketoacidosis with diabetes mellitus.
    Lindenmayer JP; Patel R
    Am J Psychiatry; 1999 Sep; 156(9):1471. PubMed ID: 10484968
    [No Abstract]   [Full Text] [Related]  

  • 35. Topiramate produced weight loss following olanzapine-induced weight gain in schizophrenia.
    Levy E; Margolese HC; Chouinard G
    J Clin Psychiatry; 2002 Nov; 63(11):1045. PubMed ID: 12469686
    [No Abstract]   [Full Text] [Related]  

  • 36. Neuroleptic malignant syndrome associated with olanzapine therapy.
    Apple JE; Van Hauer G
    Psychosomatics; 1999; 40(3):267-8. PubMed ID: 10341541
    [No Abstract]   [Full Text] [Related]  

  • 37. Neuroleptic malignant syndrome associated with risperidone and olanzapine in first-episode schizophrenia.
    Aboraya A; Schumacher J; Abdalla E; LePage J; McGhee M; Butcher D; Griffin H; Shahda M
    W V Med J; 2002; 98(2):63-5. PubMed ID: 12048741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Atypical antipsychotics and neuroleptic malignant syndrome.
    Kohen D; Bristow MF
    Br J Psychiatry; 1999 Oct; 175():392-3. PubMed ID: 10789314
    [No Abstract]   [Full Text] [Related]  

  • 39. Possible neuroleptic malignant syndrome associated with olanzapine.
    Nyfort-Hansen K; Alderman CP
    Ann Pharmacother; 2000 May; 34(5):667. PubMed ID: 10852098
    [No Abstract]   [Full Text] [Related]  

  • 40. Olanzapine and NMS.
    Hickey C; Stewart C; Lippmann S
    Psychiatr Serv; 1999 Jun; 50(6):836-7. PubMed ID: 10375159
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.